See more : Unidoc Health Corp. (UDOC.CN) Income Statement Analysis – Financial Results
Complete financial analysis of Upper Street Marketing Inc. (UPPR) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Upper Street Marketing Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Trustmark Corporation (TRMK) Income Statement Analysis – Financial Results
- The People’s Insurance Company (Group) of China Limited (PINXF) Income Statement Analysis – Financial Results
- Amazonas Florestal, Ltd (AZFL) Income Statement Analysis – Financial Results
- Spectrum Global Solutions, Inc. (SGSI) Income Statement Analysis – Financial Results
- NatureWise Biotech & Medicals Corporation (4732.TWO) Income Statement Analysis – Financial Results
Upper Street Marketing Inc. (UPPR)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.upperstreetmarketing.com
About Upper Street Marketing Inc.
Upper Street Marketing Inc. provides liquid conversion water technology for various cannabis and hemp cultivators in the United States and Canada. It also acquires and operates cannabis cultivation, dispensary, and related manufacturing operations. The company is based in Scottsdale, Arizona.
| Metric | 2023 | 2022 | 2021 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 0.00 | 8.71K | 9.59K | 16.75K | 1.55K | 0.00 | 0.00 |
| Gross Profit | 0.00 | -8.71K | -9.59K | -16.75K | -1.55K | 0.00 | 0.00 |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 57.44K | 1.00M | 1.45M | 488.46K | 35.28K | 230.31K | 341.46K |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 57.44K | 1.00M | 1.45M | 488.46K | 35.28K | 230.31K | 341.46K |
| Cost & Expenses | 57.44K | 1.01M | 1.46M | 505.21K | 36.83K | 230.31K | 341.46K |
| Interest Income | 0.00 | 0.00 | 3.05M | 0.00 | 0.00 | 14.27K | 894.00 |
| Interest Expense | 228.00 | 0.00 | 72.09K | 11.33K | 11.34K | 19.61K | 3.07K |
| Depreciation & Amortization | -200.00 | 8.71K | 9.59K | 16.75K | 1.55K | 14.27K | 890.00 |
| EBITDA | -57.64K | 169.92K | 9.48M | -488.46K | -24.63K | -216.04K | -940.57K |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -57.44K | -1.01M | -1.46M | -505.21K | -36.83K | -230.31K | -341.46K |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -432.00 | 1.17M | 10.87M | -11.33K | -681.00 | -5.34K | -602.18K |
| Income Before Tax | -57.87K | 161.22K | 9.40M | -516.55K | -37.51K | -235.65K | -943.64K |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | 1.17M | 10.94M | 1.00 | -3.00 | 0.00 | -890.00 |
| Net Income | -57.87K | 161.22K | 9.40M | -516.55K | -37.51K | -235.65K | -943.64K |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | 0.00 | 0.00 | 0.08 | -0.01 | 0.00 | 0.00 | -0.02 |
| EPS Diluted | 0.00 | 0.00 | 0.08 | -0.01 | 0.00 | 0.00 | -0.02 |
| Weighted Avg Shares Out | 143.16M | 135.01M | 125.41M | 52.72M | 37.78M | 58.44M | 58.44M |
| Weighted Avg Shares Out (Dil) | 143.16M | 135.01M | 125.41M | 52.72M | 37.78M | 58.44M | 58.44M |
Source: https://incomestatements.info
Category: Stock Reports